287 related articles for article (PubMed ID: 25194178)
1. Mechanisms behind the link between obesity and gastrointestinal cancers.
Tilg H; Moschen AR
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
Baranova A; Tran TP; Birerdinc A; Younossi ZM
Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
4. Innate immune activation in obesity.
Lumeng CN
Mol Aspects Med; 2013 Feb; 34(1):12-29. PubMed ID: 23068074
[TBL] [Abstract][Full Text] [Related]
5. Review article: steatosis, the metabolic syndrome and cancer.
Bugianesi E
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
[TBL] [Abstract][Full Text] [Related]
6. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.
Wainwright P; Scorletti E; Byrne CD
Curr Diab Rep; 2017 Apr; 17(4):20. PubMed ID: 28290049
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
Yki-Järvinen H
Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669
[TBL] [Abstract][Full Text] [Related]
8. NAFLD, NASH and liver cancer.
Michelotti GA; Machado MV; Diehl AM
Nat Rev Gastroenterol Hepatol; 2013 Nov; 10(11):656-65. PubMed ID: 24080776
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma: Increase in incidence or future plague?].
Raoul JL; Raimbourg J; Hiret S; Adhoute X; Senellart H
Bull Cancer; 2018 May; 105(5):502-507. PubMed ID: 29567280
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.
Dyson J; Jaques B; Chattopadyhay D; Lochan R; Graham J; Das D; Aslam T; Patanwala I; Gaggar S; Cole M; Sumpter K; Stewart S; Rose J; Hudson M; Manas D; Reeves HL
J Hepatol; 2014 Jan; 60(1):110-7. PubMed ID: 23978719
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.
Cani PD; Jordan BF
Nat Rev Gastroenterol Hepatol; 2018 Nov; 15(11):671-682. PubMed ID: 29844585
[TBL] [Abstract][Full Text] [Related]
13. Obesity and gastrointestinal cancer.
Donohoe CL; Pidgeon GP; Lysaght J; Reynolds JV
Br J Surg; 2010 May; 97(5):628-42. PubMed ID: 20306531
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
Sanna C; Rosso C; Marietti M; Bugianesi E
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187365
[TBL] [Abstract][Full Text] [Related]
15. Obesity, type 2 diabetes and risk of digestive cancer.
Hillon P; Guiu B; Vincent J; Petit JM
Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
[TBL] [Abstract][Full Text] [Related]
16. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
Mahli A; Hellerbrand C
Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease: an emerging pathological spectrum.
Zafrani ES
Virchows Arch; 2004 Jan; 444(1):3-12. PubMed ID: 14685853
[TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.
Ji D; Zhang M; Qin E; Zhang L; Xu J; Wang Y; Cheng G; Wang F; Lau G
Metabolism; 2021 Feb; 115():154437. PubMed ID: 33220249
[No Abstract] [Full Text] [Related]
19. [Liver disorders in diabetic patients].
Brůha R; Dvořák K; Petrtýl J
Vnitr Lek; 2013 Jul; 59(7):546-50. PubMed ID: 23909257
[TBL] [Abstract][Full Text] [Related]
20. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
